Jitongning tablets for active spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a Chinese herbal tablet called Jitongning against a placebo to see if it can improve overall symptoms in people with active axial osteoarthritis. You may be eligible if your arthritis is active, you have a specific genetic marker (HLA-B27 positive), and your inflammation levels are high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have axial osteoarthritis (a type of arthritis mainly affecting the spine and sacroiliac joints) that is currently active
- Your condition matches the traditional Chinese medicine pattern called 'kidney yang deficiency with blood stasis' (common symptoms: cold lower back pain, weak knees, dark tongue)
- Your imaging shows grade I to II sacroiliitis (mild to moderate joint inflammation on CT scan)
- You test positive for the genetic marker HLA-B27
- You have elevated inflammation markers in your blood (CRP or ESR) measured recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.
This trial tests a new medication called vilamakitug to see if it can reduce pain and inflammation in people with axial spondyloarthritis, a type of arthritis that affects the spine and joints. It may help those who haven't found relief with other treatments.
This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.
This study tests whether combining traditional Chinese medicine with standard Western treatments can help ankylosing spondylitis (a condition causing spine stiffness and inflammation) work better and improve your quality of life. Researchers will follow patients over time to see how well this combined approach works.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.